HistoSonics, Inc.

One of the most unique traditions at HistoSonics, Inc. is for our entire team to take the week of Independence Day off from work to be with family and friends, and to enjoy celebrating the Holiday with those we love. 2024 was no different and we have so many wonderful examples of our Histo Team creating lasting memories around the world. Thank you to our entire Histo Team for a great first half of 2024, especially those that continued to support our clinical partners and patients over the Holiday. We look forward to continuing the great momentum we have in 2024 and to bringing meaningful change to as many patients and their families as possible! #TeamHisto #MinimallyInvasiveIsntMinimalEnough #Family

Breaking News @ HistoSonics, Inc.: UNOS Adds Histotripsy As An Additional Therapy Option for Liver Transplant Candidates with Primary Liver Tumors The United Network for Organ Sharing (UNOS) announced that beginning July 25, 2024, the OPTN (Organ Procurement and Transplantation Network) Waiting List will be updated by adding ‘histotripsy’ as an additional loco-regional therapy option for initial and extension exception requests for liver candidates with primary liver tumors. The Edison® System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by persons who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions and a summary of clinical trial results, including reported adverse events.

The #2024SRS meeting, in Orlando, begins this Thursday June 20th and HistoSonics, Inc. looks forward to kicking off Day 1 of SRS by participating in executive panel discussions as part of MedTech Investor Day. We also invite the world's leading surgeon innovators and attendees to "Meet Edison" for hands-on demonstrations at our booth where you can target, plan and deliver non-invasive histotripsy with the Edison System to liquefy tissue in real time. #BubblesAreChangingEverything #Histotripsy #MinimallyInvasiveIsntMinimalEnough

HistoSonics, Inc. is excited to have a strong presence at the upcoming #2024SRS meeting, in Orlando, June 20th-23rd. Surgeons currently utilizing histotripsy to non-invasively destroy tumors in both the liver and kidney will be presenting their experiences using the Edison Histotripsy System. Also, members of our HistoSonics leadership team will participate in panel discussions to describe histotripsy's unique mechanism of action and how we see histotripsy impacting the future of surgery. We invite the world's leading surgeon innovators and attendees at #SRS2024 to "Meet Edison" for hands-on demonstrations at our booth #B105, and hope to see you in the many histotripsy sessions. #MeetEdison #HistoSonics #MinimallyInvasiveIsntMinimalEnough

HistoSonics, Inc. is looking forward to demonstrating our Edison Histotripsy System at the American Transplant Congress (ATC) in Philadelphis June 1st - 4th. Please stop by our Booth 725 or our Tech Suite MR2 on the exhibition floor to get hands on demonstrations and liquefy targeted tumor models with the Edison System now FDA cleared to non-invasively destroy targeted liver tumors. Stop by to see our experts and discuss the innovative use of histotripsy by transplant and hepatobiliary surgeons. #MinimallyInvasiveIsntMinimalEnough #HistoSonics #Histotripsy

This Holiday weekend HistoSonics, Inc. encourages all to take the time to remember and honor the selfless service of the men and women who made the ultimate sacrifice for the freedoms we recognize today. We strive to change the world everyday in what we do so as to be worthy of the sacrifices made by those who served and their families. #MemorialDay #HistoSonics #RememberThoseWhoServed

HistoSonics, Inc. is eager to attend this years IHPBA: International Hepato Pancreato Biliary Association congress in Cape Town, South Africa from May 15th-18th with our Edison Histotripsy System which is now cleared in the United States by the US FDA for the non-invasive destruction of liver tumors. We will have hands-on demonstration sessions and Q&A with the HistoSonics team in our "Tech Suite" with updates on Edison's current clinical in the US. To RSVP for your hands-on session with Edison, please email [email protected] or visit us at Booths B01 & B02 at the exhibition center. #histotripsy #IHPBA2024 #EdisonInCapeTown

HistoSonics, Inc. is excited to attend hashtag #AUA24 in San Antonio. We have multiple opportunities to engage with our Edison Histotripsy System, currently FDA cleared for the non-invasive destruction of liver tumors and also now under clinical trial in the US (#HOPE4KIDNEY Trial) for the non-invasive destruction of renal tumors. Please stop by Booth 1717 or our Tech Suite 2158 for a hands-on and feedback session with the Edison System and the potential for histotripsy in urologic applications. #histotripsy #InnovationInUrology #Americanurolgical

HistoSonics, Inc. is honored to receive the Edison Awards highest honor, their Gold Award for top innovations in Health, Medical and Biotechnology for 2024 for our own Edison Histotripsy System that non-invasively destroys liver tumors without needles, knives or radiation. Winners of the Edison Award, https://lnkd.in/e5eQZfed, are chosen as the “best of the best” within their respective categories by some of the world’s top senior business executives, designers, academics and innovation leaders. We at HistoSonics recognize the intrepid spirit of our founders, scientists, researchers and patients that enabled histotripsy to make it into the clinic today and to be honored for its contribution to improving the lives of so many people alongside the world’s leading innovative teams like SpaceX and Nasa’s Jet Propulsion Laboratory. We look forward to maintaining our spirit of innovation to reach more patients in more applications across the world and to partnering with physicians and hospitals who share our same desire to bring meaningful change to the lives of patients. #Histotripsy #InnovationPartners #HistoSonics

HistoSonics, Inc. is looking forward to the upcoming @AHPBA Congress in Miami. The now FDA cleared Edison Histotripsy System will be available for demonstrations and hands-on sessions with our experts. We are proud to partner with AHPBA members and their liver teams across the US who are leaders in using non-invasive histotripsy in their clinical practice to destroy liver tumors and innovate for their diverse patient populations. Come by our booth for your personal demonstration on the unique capabilities of histotripsy. Email [email protected] to RSVP for hands on with Edison. #AHPBA #InnovationPartners #histotipsy